Bli medlem
Bli medlem

Du är här


Aqua Bio Technology ASA: First order from DBK Pharmaceuticals S.A.E. confirmed

Aqua Bio Technology ASA (ABT) entered into a distribution agreement in Q4 2019 with DBK Pharmaceuticals S.A.E. (DBK) in Cairo, Egypt for distribution of the skincare series Moana Skincare. DBK is a fast growing Egyptian company in the marketing and sale of exclusive cosmetic products as well as other consumer goods. The Egyptian market for cosmetics and personal care is estimated at around NOK 30 billion and is growing rapidly.

DBK's launch of Moana has been delayed due to the Corona pandemic, but ABT has now received the first order confirming the further cooperation between ABT and DBK. The launch of the skincare series is expected to take place in Q4 after the Moana Skincare series has been registered and approved in accordance with local regulations.

For further information, please contact Espen Kvale, CEO, telephone +47 916 28 092

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users.  ABT's focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the company's strategy going forward. Aqua Bio Technology is listed on Euronext Expand.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.




Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.